Bioluminescence Imaging Correlates with Tumor Serum Marker, Organ Weights, Histology, and Human DNA Levels during Treatment of Orthotopic Tumor Xenografts with Antibodies

CYFRA 21-1: A potential molecular marker for noninvasive differential diagnosis of urothelial carcinoma of bladder

(2011) Abhigyan Satyam et al.   BIOMARKERS

Serum Tumor Markers CEA, CYFRA21-1, and CA-125 Are Associated With Worse Prognosis In Advanced Non–Small-Cell Lung Cancer (NSCLC)

(2011) Susana Cedrés et al.   Clinical Lung Cancer

Real-Time Cancer Cell Tracking by Bioluminescence in a Preclinical Model of Human Bladder Cancer Growth and Metastasis

(2011) Geertje van der Horst et al.   EUROPEAN UROLOGY

Optical imaging for the new grammar of drug discovery

(2011) T. Krucker et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES

Bioluminescence imaging: progress and applications

(2011) Christian E. Badr et al.   TRENDS IN BIOTECHNOLOGY

Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site

(2011) Rafael Molina et al.   TUMOR BIOLOGY

Clinical Usefulness of CEA, CA19-9, and CYFRA 21-1 as Tumor Markers for Urothelial Bladder Carcinoma

(2011) Satoshi Washino et al.   UROLOGIA INTERNATIONALIS

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumor therapies

(2010) Joanna Napp et al.   INTERNATIONAL JOURNAL OF CANCER

Bioluminescence imaging correlates with tumor progression in an orthotopic mouse model of lung cancer

(2010) Rafael A. Madero-Visbal et al.   SURGICAL ONCOLOGY-OXFORD

In Vivo Imaging in Cancer

(2010) J. Condeelis et al.   Cold Spring Harbor Perspectives in Biology

CYFRA21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma

(2009) Yan Yi et al.   BIOMARKERS

Guided by the light: visualizing biomolecular processes in living animals with bioluminescence

(2009) Jennifer A Prescher et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Near-infrared fluorescence: application to in vivo molecular imaging

(2009) Scott A Hilderbrand et al.   CURRENT OPINION IN CHEMICAL BIOLOGY

Contemporary pre-clinical development of anticancer agents – What are the optimal preclinical models?

(2009) Giovanna Damia et al.   EUROPEAN JOURNAL OF CANCER

Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications

(2009) Frederic Leblond et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

Monitoring with a non-invasive bioluminescent in vivo imaging system of pleural metastasis of lung carcinoma

(2009) Seiji Matsumoto et al.   LUNG CANCER

Method of bioluminescence imaging for molecular imaging of physiological and pathological processes

(2009) Olivier Gheysens et al.   METHODS

Antimetastatic Effects of Liposomal Gemcitabine and Empty Liposomes in an Orthotopic Mouse Model of Pancreatic Cancer

(2009) Ralph Graeser et al.   PANCREAS

New Automated Multiplex Assay for Bone Turnover Markers in Osteoporosis

(2008) A. Claudon et al.   CLINICAL CHEMISTRY

Molecular imaging in drug development

(2008) Jürgen K. Willmann et al.   NATURE REVIEWS DRUG DISCOVERY